Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

7.1%

1 terminated/withdrawn out of 14 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

64%

9 trials in Phase 3/4

Results Transparency

50%

6 of 12 completed trials have results

Key Signals

1 recruiting6 with results

Enrollment Performance

Analytics

Phase 3

8(61.5%)

Phase 1

2(15.4%)

Phase 4

1(7.7%)

N/A

1(7.7%)

Phase 2

1(7.7%)

13Total

Phase 3(8)

Phase 1(2)

Phase 4(1)

N/A(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

NCT05538689Phase 4Withdrawn

Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)

Role: collaborator

NCT05765500Phase 2Recruiting

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

Role: collaborator

NCT03751124Phase 3Completed

Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Role: lead

NCT05324098Not ApplicableCompleted

Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy

Role: collaborator

NCT03412890Phase 3Completed

LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Role: lead

NCT03654274Phase 3Completed

SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain

Role: lead

NCT03103087Phase 3Completed

LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Role: lead

NCT03049735Phase 3Completed

LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Role: lead

NCT03085095Phase 3Completed

A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

Role: lead

NCT04714554Phase 1Completed

A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men

Role: lead

NCT04978688Phase 1Completed

Study of Relugolix Alone and Relugolix Combined With Hormonal Add-Back Therapy in Healthy Premenopausal Female Participants

Role: lead

NCT03204331Phase 3Completed

SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

Role: lead

NCT03204318Phase 3Completed

SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

Role: lead

NCT03744507Completed

Bone Mineral Density in Women With Uterine Fibroids or Endometriosis

Role: lead

All 14 trials loaded